Organon & (OGN) Financial Statements

Price: $14.72
Market Cap: $3.80B
Avg Volume: 3.32M
Country: US
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.724
52W Range: $13.87-23.1
Website: Organon &

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Organon &.


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.002018201820192019202020202021202120222022202320232024202420252025
Operating Expenses
Operating Income
Operating Expenses & Income$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.002018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017
Revenue $6.40B $6.26B $6.17B $6.30B $8.10B $7.78B $9.78B $10.50B
Cost of Revenue $2.69B $2.52B $2.29B $2.38B $3.35B $2.27B $4.69B $4.59B
Gross Profit $3.71B $3.75B $3.88B $3.92B $4.75B $5.50B $5.08B $5.91B
Gross Profit Ratio 58.02% 59.80% 62.84% 62.20% 58.66% 70.76% 52.00% 56.30%
Research and Development Expenses $469.00M $528.00M $471.00M $443.00M $304.00M $220.00M $365.00M $355.00M
General and Administrative Expenses $- $1.68B $1.45B $1.43B $1.47B $1.18B $1.69B $1.93B
Selling and Marketing Expenses $- $209.00M $255.00M $236.00M $198.00M $262.00M $322.00M $356.00M
Selling General and Administrative Expenses $1.76B $1.89B $1.70B $1.67B $1.67B $1.44B $2.01B $2.29B
Other Expenses $- $- $-15.00M $-279.00M $-29.00M $7.00M $142.00M $-
Operating Expenses $2.23B $2.42B $2.17B $2.11B $1.97B $1.66B $2.38B $2.64B
Cost and Expenses $4.92B $4.94B $4.47B $4.49B $5.32B $3.94B $7.07B $7.23B
Interest Income $- $- $422.00M $258.00M $- $19.00M $- $11.00M
Interest Expense $520.00M $527.00M $422.00M $258.00M $6.00M $6.00M $- $-
Depreciation and Amortization $277.00M $236.00M $212.00M $195.00M $142.00M $354.00M $1.67B $1.97B
EBITDA $1.60B $1.44B $1.69B $1.81B $2.99B $4.18B $4.38B $5.08B
EBITDA Ratio 25.05% 22.93% 27.37% 28.78% 37.13% 53.75% 46.01% 49.95%
Operating Income $1.49B $1.33B $1.48B $1.62B $2.85B $3.85B $2.71B $3.27B
Operating Income Ratio 23.21% 21.19% 23.94% 25.68% 35.19% 49.47% 27.68% 31.16%
Total Other Income Expenses Net $-679.00M $-654.00M $-583.00M $-386.00M $-95.00M $-144.00M $23.00M $-173.00M
Income Before Tax $807.00M $673.00M $1.12B $1.53B $2.68B $3.70B $2.73B $3.10B
Income Before Tax Ratio 12.60% 10.75% 18.17% 24.25% 33.10% 47.52% 27.91% 29.51%
Income Tax Expense $-57.00M $-350.00M $205.00M $178.00M $520.00M $390.00M $576.00M $1.30B
Net Income $864.00M $1.02B $917.00M $1.35B $2.16B $3.22B $2.15B $1.80B
Net Income Ratio 13.49% 16.33% 14.85% 21.43% 26.68% 41.38% 22.02% 17.15%
EPS $3.36 $4.01 $3.61 $5.33 $8.52 $12.71 $8.51 $7.11
EPS Diluted $3.33 $3.99 $3.59 $5.33 $8.52 $12.71 $8.51 $7.11
Weighted Average Shares Outstanding 257.05M 255.24M 254.08M 253.55M 253.52M 253.13M 253.13M 253.13M
Weighted Average Shares Outstanding Diluted 259.15M 256.27M 255.17M 253.55M 253.52M 253.13M 253.13M 253.13M
SEC Filing Source Source Source Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$15.00B$15.00B$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.0020192019202020202021202120222022202320232024202420252025
Equity$8.00B$8.00B$6.00B$6.00B$4.00B$4.00B$2.00B$2.00B$0.00$0.00-$2.00B-$2.00B20192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Cash and Cash Equivalents $675.00M $693.00M $706.00M $737.00M $500.00M $319.00M $244.00M
Short Term Investments $- $- $- $- $- $- $-
Cash and Short Term Investments $675.00M $693.00M $706.00M $737.00M $500.00M $319.00M $244.00M
Net Receivables $1.36B $1.74B $1.48B $1.38B $1.09B $1.56B $1.59B
Inventory $1.32B $1.31B $1.00B $915.00M $913.00M $1.07B $994.00M
Other Current Assets $994.00M $756.00M $747.00M $726.00M $1.55B $1.00B $883.00M
Total Current Assets $4.35B $4.51B $3.93B $3.76B $3.43B $3.96B $3.71B
Property Plant Equipment Net $1.17B $1.18B $1.02B $973.00M $984.00M $680.00M $651.00M
Goodwill $4.68B $4.60B $4.60B $4.60B $4.60B $4.60B $4.60B
Intangible Assets $1.41B $533.00M $649.00M $651.00M $503.00M $569.00M $812.00M
Goodwill and Intangible Assets $6.09B $5.14B $5.25B $5.25B $5.11B $5.17B $5.42B
Long Term Investments $- $- $- $-4.00M $- $- $-
Tax Assets $- $- $19.00M $4.00M $- $- $-
Other Non-Current Assets $1.49B $1.23B $735.00M $694.00M $910.00M $741.00M $714.00M
Total Non-Current Assets $8.75B $7.55B $7.02B $6.92B $7.00B $6.59B $6.78B
Other Assets $- $- $- $- $- $- $-
Total Assets $13.10B $12.06B $10.96B $10.68B $10.43B $10.55B $10.49B
Account Payables $1.15B $1.31B $1.13B $1.38B $259.00M $258.00M $289.00M
Short Term Debt $20.00M $9.00M $8.00M $9.00M $16.00M $34.00M $-207.00M
Tax Payables $134.00M $206.00M $184.00M $185.00M $109.00M $242.00M $322.00M
Deferred Revenue $- $- $19.00M $- $-8.00M $- $322.00M
Other Current Liabilities $1.41B $1.39B $1.19B $1.02B $2.29B $807.00M $497.00M
Total Current Liabilities $2.72B $2.92B $2.51B $2.60B $1.20B $1.34B $1.54B
Long Term Debt $8.86B $8.88B $9.05B $9.31B $46.00M $70.00M $34.00M
Deferred Revenue Non-Current $- $- $- $- $-23.00M $- $-
Deferred Tax Liabilities Non-Current $74.00M $47.00M $19.00M $4.00M $121.00M $139.00M $149.00M
Other Non-Current Liabilities $977.00M $287.00M $261.00M $279.00M $1.90B $1.96B $2.57B
Total Non-Current Liabilities $9.91B $9.21B $9.34B $9.59B $10.05B $2.17B $2.60B
Other Liabilities $- $- $- $- $- $- $-
Total Liabilities $12.63B $12.13B $11.85B $12.19B $11.25B $3.51B $4.15B
Preferred Stock $- $- $- $- $- $- $-
Common Stock $3.00M $3.00M $3.00M $3.00M $3.00M $7.95B $7.26B
Retained Earnings $1.01B $443.00M $-331.00M $-998.00M $-219.00M $- $-
Accumulated Other Comprehensive Income Loss $-649.00M $-541.00M $-564.00M $-513.00M $-604.00M $-914.00M $-908.00M
Other Total Stockholders Equity $108.00M $25.00M $- $- $- $- $-
Total Stockholders Equity $472.00M $-70.00M $-892.00M $-1.51B $-820.00M $7.04B $6.35B
Total Equity $472.00M $-70.00M $-892.00M $-1.51B $-820.00M $7.04B $6.35B
Total Liabilities and Stockholders Equity $13.10B $12.06B $10.96B $10.68B $10.43B $10.55B $10.49B
Minority Interest $- $- $- $- $- $- $-
Total Liabilities and Total Equity $13.10B $12.06B $10.96B $10.68B $10.43B $10.55B $10.49B
Total Investments $- $-47.00M $- $-4.00M $- $- $-
Total Debt $8.88B $8.76B $8.91B $9.13B $31.00M $104.00M $149.00M
Net Debt $8.21B $8.07B $8.21B $8.40B $-469.00M $-215.00M $-95.00M

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00-$1.00B-$1.00B2018201820192019202020202021202120222022202320232024202420252025
Financing Cash Flow$0.00$0.00-$1.00B-$1.00B-$2.00B-$2.00B-$3.00B-$3.00B-$4.00B-$4.00B-$5.00B-$5.00B2018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017
Net Income $864.00M $1.02B $917.00M $1.35B $2.16B $3.31B $2.15B $1.80B
Depreciation and Amortization $132.00M $236.00M $212.00M $195.00M $157.00M $333.00M $1.67B $1.97B
Deferred Income Tax $-160.00M $-485.00M $-18.00M $-288.00M $6.00M $12.00M $37.00M $-1.04B
Stock Based Compensation $105.00M $101.00M $75.00M $59.00M $40.00M $41.00M $56.00M $56.00M
Change in Working Capital $- $-155.00M $-452.00M $702.00M $-197.00M $-672.00M $-174.00M $-1.44B
Accounts Receivables $383.00M $-212.00M $-123.00M $-277.00M $159.00M $200.00M $250.00M $533.00M
Inventory $-131.00M $-230.00M $-220.00M $-138.00M $-29.00M $-91.00M $44.00M $72.00M
Accounts Payables $-157.00M $163.00M $-237.00M $663.00M $27.00M $-35.00M $20.00M $-14.00M
Other Working Capital $- $124.00M $128.00M $454.00M $-354.00M $-746.00M $-488.00M $-2.03B
Other Non Cash Items $-2.00M $79.00M $124.00M $439.00M $7.00M $-253.00M $-58.00M $5.48B
Net Cash Provided by Operating Activities $939.00M $799.00M $858.00M $2.46B $2.19B $2.77B $3.69B $3.42B
Investments in Property Plant and Equipment $-175.00M $-259.00M $-427.00M $-488.00M $-278.00M $-92.00M $-101.00M $-86.00M
Acquisitions Net $-166.00M $-2.00M $-124.00M $-185.00M $5.00M $7.00M $32.00M $30.00M
Purchases of Investments $- $- $- $- $- $- $- $-
Sales Maturities of Investments $- $- $- $- $- $- $- $-
Other Investing Activities $-172.00M $1.00M $131.00M $192.00M $15.00M $-17.00M $32.00M $30.00M
Net Cash Used for Investing Activities $-513.00M $-260.00M $-420.00M $-481.00M $-258.00M $-102.00M $-69.00M $-56.00M
Debt Repayment $-11.00M $-258.00M $-108.00M $7.85B $1.51B $- $59.00M $-4.00M
Common Stock Issued $- $- $11.00M $- $- $- $- $-
Common Stock Repurchased $- $-17.00M $-11.00M $- $- $- $- $-
Dividends Paid $-297.00M $-294.00M $-290.00M $-145.00M $- $- $- $-
Other Financing Activities $-60.00M $-17.00M $-35.00M $-9.03B $-3.69B $-2.62B $-4.22B $-3.37B
Net Cash Used Provided by Financing Activities $-368.00M $-569.00M $-433.00M $-1.33B $-2.17B $-2.62B $-4.16B $-3.37B
Effect of Forex Changes on Cash $-76.00M $17.00M $-36.00M $23.00M $-3.00M $31.00M $19.00M $-36.00M
Net Change in Cash $-18.00M $-13.00M $-31.00M $667.00M $-249.00M $75.00M $-527.00M $-45.00M
Cash at End of Period $675.00M $693.00M $706.00M $737.00M $70.00M $319.00M $244.00M $771.00M
Cash at Beginning of Period $693.00M $706.00M $737.00M $70.00M $319.00M $244.00M $771.00M $816.00M
Operating Cash Flow $939.00M $799.00M $858.00M $2.46B $2.19B $2.77B $3.69B $3.42B
Capital Expenditure $-175.00M $-261.00M $-427.00M $-488.00M $-278.00M $-92.00M $-101.00M $-86.00M
Free Cash Flow $764.00M $538.00M $431.00M $1.97B $1.91B $2.67B $3.59B $3.33B